Page last updated: 2024-09-03

troxacitabine and Leukemia

troxacitabine has been researched along with Leukemia in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	11 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Giles, FJ	2
Karrison, T; Ratain, M	1
Gourdeau, H; Jolivet, J	1
Baccarani, M; Belanger, R; Ben-Yehuda, D; Caballero, D; Coiffier, B; Facon, T; Fanin, R; Giles, F; Gregory, SA; Panwalkar, A; Vose, JM	1
Giles, F; Swords, R	1
Apostolidou, E; Giles, F; Swords, R	1
Baker, SD; Beran, M; Bivins, C; Cortes, JE; Giles, FJ; Jolivet, J; Kantarjian, HM; O'Brien, S; Smith, TL; Thomas, DA	1
Cass, CE; Clarke, ML; Gourdeau, H; Jolivet, J; Lafrenière, RG; Lee, N; Mackey, JR; Mowles, D; Ouellet, F; Richard, A; Selner, M; Young, JD	1
Andreeff, M; Baker, SD; Bivins, C; Cortes, JE; Garcia-Manero, G; Giles, FJ; Jolivet, J; Kantarjian, HM; Miller, CB; O'Brien, SM; Thomas, DA	1
Cortes, JE; Giles, FJ; Hui, YF	1

Reviews

5 review(s) available for troxacitabine and Leukemia

Article	Year
Troxacitabine-based therapy of refractory leukemia. Expert review of anticancer therapy, 2002, Volume: 2, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Cytosine; Dioxolanes; Humans; Idarubicin; Leukemia; Remission Induction; Topotecan	2002
[Troxacitabine]. Bulletin du cancer, 2004, Volume: 91, Issue:3 Topics: Acute Disease; Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytosine; Dioxolanes; Drug Screening Assays, Antitumor; Humans; Leukemia; Neoplasms	2004
Troxacitabine in acute leukemia. Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:3 Topics: Antineoplastic Agents; Cytosine; Dioxolanes; Humans; Leukemia; Treatment Outcome	2007
Troxacitabine in leukemia. Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:5 Topics: Antineoplastic Agents; Cytosine; Dioxolanes; Humans; Leukemia; Treatment Outcome	2006
Novel agents for the therapy of acute leukemia. Current opinion in oncology, 2002, Volume: 14, Issue:1 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Azacitidine; Cysteine Endopeptidases; Cytosine; Decitabine; Dioxolanes; DNA Methylation; Humans; Leukemia; Multienzyme Complexes; Neovascularization, Pathologic; Proteasome Endopeptidase Complex	2002

Trials

3 trial(s) available for troxacitabine and Leukemia

Article	Year
A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma. Leukemia & lymphoma, 2007, Volume: 48, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Cytosine; Dioxolanes; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Models, Biological; Multiple Myeloma; Recurrence; Salvage Therapy; Survival Analysis; Treatment Outcome	2007
Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-01, Volume: 19, Issue:3 Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Blast Crisis; Cytosine; Dioxolanes; Dose-Response Relationship, Drug; Female; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2001
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Feb-01, Volume: 20, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cytosine; Dioxolanes; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction	2002

Other Studies

3 other study(ies) available for troxacitabine and Leukemia

Article	Year
Troxacitabine in patients with refractory leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Aug-01, Volume: 20, Issue:15 Topics: Antineoplastic Agents; Area Under Curve; Clinical Trials, Phase II as Topic; Cytosine; Dioxolanes; Humans; Leukemia; Treatment Outcome	2002
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines. Cancer research, 2001, Oct-01, Volume: 61, Issue:19 Topics: Amino Acid Sequence; Antineoplastic Agents; Biological Transport; Carrier Proteins; Cytarabine; Cytidine Deaminase; Cytosine; Deoxycytidine; Deoxycytidine Kinase; Dioxolanes; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia; Male; Membrane Proteins; Molecular Sequence Data; Nucleoside Transport Proteins; Phosphorylation; Prostatic Neoplasms; Sequence Homology, Amino Acid; Sodium; Stereoisomerism; Tritium; Tumor Cells, Cultured; Uridine	2001
Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome--recall following different chemotherapy agents. Investigational new drugs, 2002, Volume: 20, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytosine; Dioxolanes; Erythema; Female; Foot; Hand; Humans; Leukemia; Male; Middle Aged; Paresthesia; Recurrence; Syndrome	2002